Matthew S-m Kim is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of RNA-based delivery systems. With a total of 2 patents, his work focuses on innovative methods for delivering polynucleotides to target cells.

Latest Patents

Matthew's latest patents include groundbreaking technologies related to RNA-based delivery systems. These patents disclose methods, compositions, and systems suitable for delivering a polynucleotide to a target cell of a subject in need. In some embodiments, the viral vector comprises a polynucleotide encoding nucleoprotein (N), phosphoprotein (P), matrix protein (M), RNA-dependent RNA polymerase (L), and one or more transgenes. The viral vector can also include a conditionally stable fusion protein, a protease fusion protein, a degron fusion protein, and/or a glycoprotein derived from another species than the viral vector polynucleotide. This enables enhanced control of viral vector transduction and/or replication.

Career Highlights

Matthew S-m Kim is affiliated with the California Institute of Technology, where he continues to advance his research in RNA delivery systems. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

Some of Matthew's notable coworkers include Xiaojing Gao and Michael B Elowitz. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Matthew S-m Kim is a distinguished inventor whose work in RNA-based delivery systems is paving the way for future innovations in biotechnology. His contributions are vital to the ongoing development of effective therapeutic strategies.